La Capitale concludes a partnership with BiogeniQ to support its new disability claims management approach
December 18, 2019 – La Capitale Insurance and Financial Services has signed a partnership agreement with BiogeniQ, a Quebec-based health management company, to complete its integrated disability claims management process, which is based on a comprehensive approach to mental health.
In partnership with BiogeniQ (a subsidiary of Biron Health Group), La Capitale is offering optimization of the therapeutic approach through pharmacogenetics. Certain insureds who agree to be involved in the process will have an opportunity to undergo genetic testing that can limit the side effects and the trial-and-error cycles associated with the use of medication. The test results are confidential and are not, under any circumstances, shared with La Capitale. The information is sent only to the attending physician, allowing him or her to identify the preferred medications and optimize the treatment prescribed.
“It can be difficult to find the right drug at the right dosage, and it can cause someone who wants to get better to lose precious time. BiogeniQ uses pharmacogenetics to determine the best treatment for individual patients and increase its likelihood of success. BiogeniQ proud to partner with La Capitale by allowing its expertise to be used for the benefit of insureds,” said Jean-François Rioux, Vice-President of Sales and Marketing at Biron Health Group.
The use of pharmacogenetics though BiogeniQ is part of La Capitale’s integrated disability claims management process, which is based on a comprehensive approach to mental health. This innovative solution has now been made available to insureds under a La Capitale group insurance plan, enabling them to optimize their treatment and improve their well-being.
La Capitale’s comprehensive approach to mental health
The continually rising costs associated with disability related to mental health pose a challenge for employers wishing to offer affordable, quality coverage to their employees. La Capitale’s comprehensive approach to mental health aims to promote a faster return to health and thus shorten disability periods.
This innovative integrated approach is part of La Capitale’s health and wellness continuum, which offers interventions that focus on individual participants and their specific needs.
About La Capitale
La Capitale Insurance and Financial Services, created in 1940, has a strong presence across Quebec and throughout Canada. With over 2,600 employees and guided by the values of mutualism on which it was founded, La Capitale works with clients to build, protect and value what they feel counts for their financial security. It offers insurance products and financial services to the general public, as well as to Quebec public service employees. With assets of $7.4 billion, La Capitale occupies a choice position among leading insurers in Canada.
BiogeniQ is a Canadian company in the field of genetics that offers DNA testing. Its team of genetic specialists provides advice and recommends personalized treatments to support attending physicians. A quick, simple test allows BiogeniQ to detect a person’s risk of developing or transmitting a genetic disease, determine which drugs could potentially be harmful and provide advice on diet in relation to the genetic profile. BiogeniQ has been a Biron Health Group subsidiary since 2018.
– 30 –